TR201716155A1 - Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon. - Google Patents

Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon. Download PDF

Info

Publication number
TR201716155A1
TR201716155A1 TR2017/16155A TR201716155A TR201716155A1 TR 201716155 A1 TR201716155 A1 TR 201716155A1 TR 2017/16155 A TR2017/16155 A TR 2017/16155A TR 201716155 A TR201716155 A TR 201716155A TR 201716155 A1 TR201716155 A1 TR 201716155A1
Authority
TR
Turkey
Prior art keywords
corticosteroid
agonist
beta
combination
pharmaceutical formulation
Prior art date
Application number
TR2017/16155A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/16155A priority Critical patent/TR201716155A1/tr
Publication of TR201716155A1 publication Critical patent/TR201716155A1/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, vilanterol ve flutikazondan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.
TR2017/16155A 2017-10-19 2017-10-19 Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon. TR201716155A1 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/16155A TR201716155A1 (tr) 2017-10-19 2017-10-19 Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/16155A TR201716155A1 (tr) 2017-10-19 2017-10-19 Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon.

Publications (1)

Publication Number Publication Date
TR201716155A1 true TR201716155A1 (tr) 2019-05-21

Family

ID=67954790

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/16155A TR201716155A1 (tr) 2017-10-19 2017-10-19 Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon.

Country Status (1)

Country Link
TR (1) TR201716155A1 (tr)

Similar Documents

Publication Publication Date Title
CY1125595T1 (el) Σκευασμα ξηρης σκονης που περιλαμβανει ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο για χορηγηση δια εισπνοης
MX388733B (es) Polvos secos antifungicos.
MX378273B (es) Compuestos activos hacia bromodominios.
MA55571A (fr) Compositions pharmaceutiques comprenant n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
PT3019153T (pt) Formulação de pó seco que compreende um anticolinérgico, um corticosteroide e um beta-adrenérgico para administração por inalação
CO2019008103A2 (es) Composiciones farmacéuticas para terapia de combinación
BR112019001233A2 (pt) formulação farmacêutica e uso da mesma
CY1124475T1 (el) Μια διεργασια για την παρασκευη ενος σκευασματος ξηρης σκονης που περιλαμβανει ενα αντιχολινεργικο, ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
CL2018003338A1 (es) Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant.
HUE056223T2 (hu) Kalcipotriolt és betametazon-dipropionátot tartalmazó topikális készítmény
HUE057871T2 (hu) Gyógyászati hatóanyagokat tartalmazó hialuronán konjugátumok, eljárások és kompozíciók
TR201902687T4 (tr) İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.
MX391574B (es) Partículas coloidales para su uso en medicina.
PH12018502139A1 (en) Phosphaplatin liquid formulations
CO2017003989A2 (es) Composición herbicida y proceso para prepararla
TR201716155A1 (tr) Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon.
MX2017013634A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
EP3210614A4 (en) Composition containing thymosin beta 4, and pharmaceutical formulation comprising same
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis
TR201714728A1 (tr) Beta-2 Agonist ve Kortikosteroid içeren kuru toz formülasyonu.
TR201714893A1 (tr) Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi.
TR201714725A1 (tr) Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu
TR201716207A2 (tr) Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar.
TR200907913A2 (tr) İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim